{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T04:51:17Z","timestamp":1773895877305,"version":"3.50.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,7,29]],"date-time":"2019-07-29T00:00:00Z","timestamp":1564358400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,7,29]],"date-time":"2019-07-29T00:00:00Z","timestamp":1564358400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1038\/s41409-019-0626-x","type":"journal-article","created":{"date-parts":[[2019,7,29]],"date-time":"2019-07-29T10:21:36Z","timestamp":1564395696000},"page":"332-340","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Vitiligo following stem-cell transplant"],"prefix":"10.1038","volume":"55","author":[{"given":"Alessio","family":"Totani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hossam","family":"Amin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Bacchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,7,29]]},"reference":[{"key":"626_CR1","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.jaad.2010.11.061","volume":"65","author":"A Alikhan","year":"2011","unstructured":"Alikhan A, Felsten LM, Daly M, Petronic-Rosic V. Vitiligo: a comprehensive overview Part I. Introduction, epidemiology, quality of life, diagnosis, differential diagnosis, associations, histopathology, etiology, and work-up. J Am Acad Dermatol. 2011;65:473\u201391.","journal-title":"J Am Acad Dermatol"},{"key":"626_CR2","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.exphem.2016.04.005","volume":"44","author":"M Byrne","year":"2016","unstructured":"Byrne M, Savani BN, Mohty M, Nagler A. Peripheral blood stem cell versus bone marrow transplantation: A perspective from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. Exp Hematol. 2016;44:567\u201373.","journal-title":"Exp Hematol"},{"key":"626_CR3","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.jaad.2016.08.064","volume":"76","author":"JM Bae","year":"2017","unstructured":"Bae JM, Choi KH, Jung HM, Kim SY, Kim M, Kim GM, et al. Subsequent vitiligo after hematopoietic stem cell transplantation: a nationwide population-based cohort study from Korea. J Am Acad Dermatol. 2017;76:459\u201363.","journal-title":"J Am Acad Dermatol"},{"key":"626_CR4","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1067\/mjd.2002.117215","volume":"46","author":"A Alajlan","year":"2002","unstructured":"Alajlan A, Alfadley A, Pedersen K-T. Transfer of vitiligo after allogeneic bone marrow transplantation. J Am Acad Dermatol. 2002;46:606\u201310.","journal-title":"J Am Acad Dermatol"},{"key":"626_CR5","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1046\/j.1365-2133.2001.04500.x","volume":"145","author":"WY Au","year":"2001","unstructured":"Au WY, Yeung CK, Chan HH, Lie AK. Generalized vitiligo after lymphocyte infusion for relapsed leukaemia. Br J Dermatol. 2001;145:1015\u20137.","journal-title":"Br J Dermatol"},{"key":"626_CR6","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/sj.bmt.1705137","volume":"36","author":"A Campbell-Fontaine","year":"2005","unstructured":"Campbell-Fontaine A, Coad JE, Kovach R, Ericson SG. Adoptive transfer of vitiligo after allogeneic peripheral blood stem cell transplant. Bone Marrow Transpl. 2005;36:745\u20136.","journal-title":"Bone Marrow Transpl"},{"key":"626_CR7","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/MPH.0b013e31806210ef","volume":"29","author":"S Cathcart","year":"2007","unstructured":"Cathcart S, Morrell D. Vitiligo as a post-bone marrow transplantation complication. J Pediatr Hematol\/Oncol. 2007;29:485\u20137.","journal-title":"J Pediatr Hematol\/Oncol"},{"key":"626_CR8","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1080\/00015550410021556","volume":"85","author":"SB Cho","year":"2005","unstructured":"Cho SB, Roh MR, Chung KY, Lee K-H, Park Y-K. Generalized vitiligo after allogeneic bone marrow transplantation. Acta Derm-Venereol. 2005;85:82\u20133.","journal-title":"Acta Derm-Venereol"},{"key":"626_CR9","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1111\/j.1365-2230.2011.04044.x","volume":"36","author":"M Fukumoto","year":"2011","unstructured":"Fukumoto M, Murao K, Watanabe H, Kubo Y, Arase S. Generalized hypopigmented macules after bone-marrow transplantation. Clin Exp Dermatol. 2011;36:803\u20134.","journal-title":"Clin Exp Dermatol"},{"key":"626_CR10","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/sj.bmt.1705451","volume":"38","author":"M Hirokawa","year":"2006","unstructured":"Hirokawa M, Kume M, Wu T, Ishikawa K, Sawada KI. Laryngeal stenosis associated with chronic graft-versus-host disease following unrelated bone marrow transplantation. Bone Marrow Transpl. 2006;38:387\u20138.","journal-title":"Bone Marrow Transpl"},{"key":"626_CR11","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/sj.bmt.1703724","volume":"30","author":"DA Jacobsohn","year":"2002","unstructured":"Jacobsohn DA, Ruble K, Moresi JM, Vogelsang GB. Rapid-onset leucodrema associated with graft-versus-host disease. Bone Marrow Transpl. 2002;30:705\u20136.","journal-title":"Bone Marrow Transpl"},{"key":"626_CR12","doi-asserted-by":"crossref","first-page":"90","DOI":"10.5021\/ad.2016.28.1.90","volume":"28","author":"S Jang","year":"2016","unstructured":"Jang S, Kim IS, Youn SW. Chronic graft-versus-host disease mimicking psoriasis in a patient with hemophagocytic lymphohistiocytosis. Ann Dermatol. 2016;28:90\u20133.","journal-title":"Ann Dermatol"},{"key":"626_CR13","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1001\/archdermatol.2012.335","volume":"148","author":"EC Kami\u0144ska","year":"2012","unstructured":"Kami\u0144ska EC, Larson RA, Petronic-Rosic V. Amelanocytic anhidrotic alopecia areata-like phenotype after allogeneic hematopoietic cell transplant. Arch Dermatol. 2012;148:931\u20134.","journal-title":"Arch Dermatol"},{"key":"626_CR14","first-page":"146","volume":"14","author":"HY Kang","year":"2004","unstructured":"Kang HY, Kang WH. Leukomelanoderma following acute cutaneous graft-versus-host disease. Eur J Dermatol. 2004;14:146\u20139.","journal-title":"Eur J Dermatol"},{"key":"626_CR15","first-page":"bcr06.2009.1941","volume":"2009","author":"HT Lee","year":"2009","unstructured":"Lee HT, Chen WS, Chou CT, Chen MH, Tsai CY. Chronic graft-versus-host disease mimicking rapid progressive rheumatoid arthritis with atlantoaxial subluxation. BMJ Case Rep. 2009;2009:bcr06.2009.1941.","journal-title":"BMJ Case Rep"},{"key":"626_CR16","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1684\/ejd.2013.2085","volume":"23","author":"A Martin-Gorgojo","year":"2013","unstructured":"Martin-Gorgojo A, Martin JM, Gavrilova M, Monteagudo C, Jord\u00e1-Cuevas E. Chronic graft-versus-host disease presenting with coexisting diffuse melanoderma and hypopigmented patches: a peculiar presentation. Eur J Dermatol. 2013;23:553\u20135.","journal-title":"Eur J Dermatol"},{"key":"626_CR17","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1111\/j.1346-8138.2010.01185.x","volume":"38","author":"KTM Masunaga","year":"2011","unstructured":"Masunaga KTM, Kokuba H, Takahara M, Ohyama B, Hashimoto T, Furue M. Mucous membrane pemphigoid with antibodies to the b3 subunit of laminin 332. J Dermatol. 2011;38:1082\u20134.","journal-title":"J Dermatol"},{"key":"626_CR18","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1111\/j.1399-3046.2008.01093.x","volume":"13","author":"F Mellouli","year":"2009","unstructured":"Mellouli F, Ksouri H, Dhouib N, Torjmen L, Abdelkefi A, Ladeb S, et al. Possible transfer of vitiligo by allogeneic bone marrow transplantation: a case report. Pediatr Transplant. 2009;13:1058\u201361.","journal-title":"Pediatr Transplant"},{"key":"626_CR19","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1111\/1346-8138.12407","volume":"41","author":"T Miura","year":"2014","unstructured":"Miura T, Yamamoto T. Post-herpetic vitiligo in an 8-year-old boy with immunosuppression. J Dermatol. 2014;41:270\u20131.","journal-title":"J Dermatol"},{"key":"626_CR20","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/jjco\/hys184","volume":"43","author":"Y Miyawaki","year":"2013","unstructured":"Miyawaki Y, Imoto I, Tokairin Y, Kawada K, Nakajima Y, Nishikage T, et al. Esophageal squamous cell carcinoma developed 11 years after allogeneic bone marrow transplantation for acute lymphatic leukemia. Jpn J Clin Oncol. 2013;43:69\u201373.","journal-title":"Jpn J Clin Oncol"},{"key":"626_CR21","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1111\/j.1365-2133.1996.tb06991.x","volume":"134","author":"A Nagler","year":"1996","unstructured":"Nagler A, Levi-Schaffer F, Bystryn JC, Klaus SN. Total leucoderma: a rare manifestation of cutaneous chronic graft-versus-host disease. Br J Dermatol. 1996;134:780\u20133.","journal-title":"Br J Dermatol"},{"key":"626_CR22","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/bmt.2013.200","volume":"49","author":"VE Nambudiri","year":"2014","unstructured":"Nambudiri VE, Tsiaras WG, Schmidt BA, Huang JT. Total leukoderma and leukotrichia in a child after hematopoietic SCT: report of a case and review of the literature. Bone Marrow Transpl. 2014;49:460\u20132.","journal-title":"Bone Marrow Transpl"},{"key":"626_CR23","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1016\/S0140-6736(00)02120-6","volume":"355","author":"P Neumeister","year":"2000","unstructured":"Neumeister P, Strunk D, Apfelbeck U, Sill H, Linkesch W. Adoptive transfer of vitiligo after allogeneic bone marrow transplantation for non-Hodgkin\u2019s lymphoma. Lancet. 2000;355:1334\u20135.","journal-title":"Lancet"},{"key":"626_CR24","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1684\/ejd.2015.2664","volume":"26","author":"N Oiso","year":"2016","unstructured":"Oiso N, Kawada A. Vitiligo and remarkable freckles in chronic graft-versus-host disease. Eur J Dermatol. 2016;26:91\u20132.","journal-title":"Eur J Dermatol"},{"key":"626_CR25","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1159\/000117705","volume":"216","author":"H Sanli","year":"2008","unstructured":"Sanli H, Akay BN, Arat M, Kocyigit P, Akan H, Beksac M, et al. Vitiligo after hematopoietic cell transplantation: six cases and review of the literature. Dermatology. 2008;216:349\u201354.","journal-title":"Dermatology"},{"key":"626_CR26","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1136\/bjo.87.11.1421-a","volume":"87","author":"NG Strouthidis","year":"2003","unstructured":"Strouthidis NG, Francis PJ, Stanford MR, Graham EM, Holder GE, Bird AC. Posterior segment complications of graft versus host disease after bone marrow transplantation. Br J Ophthalmol. 2003;87:1421\u20133.","journal-title":"Br J Ophthalmol"},{"key":"626_CR27","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1365-2133.2011.10341.x","volume":"165","author":"AW Tan","year":"2011","unstructured":"Tan AW, Koh LP, Goh BK. Leucoderma in chronic graft-versus-host disease: excellent repigmentation with noncultured cellular grafting. Br J Dermatol. 2011;165:435\u20137.","journal-title":"Br J Dermatol"},{"key":"626_CR28","doi-asserted-by":"crossref","first-page":"470","DOI":"10.4103\/0019-5154.164364","volume":"60","author":"H Tang","year":"2015","unstructured":"Tang H, Wang C, Fu L, Xu AE. Successful repigmentation of vitiligo after allogeneic bone marrow transplantation for hodgkin\u2019s lymphoma by autologous noncultured melanocyte-keratinocyte transplantation. Indian J Dermatol. 2015;60:470\u20132.","journal-title":"Indian J Dermatol"},{"key":"626_CR29","first-page":"172","volume":"158","author":"JS Williams","year":"2008","unstructured":"Williams JS, Mufti GJ, Du Vivier AWP, Salisbury JR, Creamer D. Leucoderma and leucotrichia in association with chronic cutaneous graft-versus-host disease. Br J Dermatol. 2008;158:172\u20134.","journal-title":"Br J Dermatol"},{"key":"626_CR30","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1001\/archderm.147.12.1460","volume":"147","author":"S Worswick","year":"2011","unstructured":"Worswick S, Pirouz A, Lee DJ. Depigmented macules following autologous bone-marrow transplant. Arch Dermatol. 2011;147:1460\u20131.","journal-title":"Arch Dermatol"},{"key":"626_CR31","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.jaad.2005.07.053","volume":"54","author":"CC Chan","year":"2006","unstructured":"Chan CC, Yao M, Tsai TF. Diffuse depigmentation in a patient with chronic myeloid leukemia. J Am Acad Dermatol. 2006;54:738\u201340.","journal-title":"J Am Acad Dermatol"},{"key":"626_CR32","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3325\/cmj.2016.57.229","volume":"57","author":"R \u010ceovi\u0107","year":"2016","unstructured":"\u010ceovi\u0107 R, Desnica L, Pulani\u0107 D, Serventi Seiwerth R, Ili\u0107 I, Grce M, et al. High frequency of cutaneous manifestations including vitiligo and alopecia areata in a prospective cohort of patients with chronic graft-vs-host disease. Croat Med J. 2016;57:229\u201338.","journal-title":"Croat Med J"},{"key":"626_CR33","first-page":"581657","volume":"2014","author":"A Khalil","year":"2014","unstructured":"Khalil A, Zaidman I, Bergman R, Elhasid R, Ben-Arush MW. Autoimmune complications after hematopoietic stem cell transplantation in children with nonmalignant disorders. ScientificWorldJournal. 2014;2014:581657.","journal-title":"ScientificWorldJournal"},{"key":"626_CR34","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.bbmt.2013.04.021","volume":"19","author":"AJ Kumar","year":"2013","unstructured":"Kumar AJ, Hexner EO, Frey NV, Luger SM, Loren AW, Reshef R, et al. Pilot study of prophylactic ex vivo costimulated donor leukocyte infusion after reduced-intensity conditioned allogeneic stem cell transplantation. Biol Blood Marrow Transplant. 2013;19:1094\u2013101.","journal-title":"Biol Blood Marrow Transplant"},{"key":"626_CR35","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1007\/s10875-009-9285-9","volume":"29","author":"PP Lee","year":"2009","unstructured":"Lee PP, Chen TX, Jiang LP, Chen J, Chan KW, Lee TL, et al. Clinical and molecular characteristics of 35 Chinese children with Wiskott\u2013Aldrich syndrome. J Clin Immunol. 2009;29:490\u2013500.","journal-title":"J Clin Immunol"},{"key":"626_CR36","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/j.jaci.2011.05.031","volume":"128","author":"N Marcus","year":"2011","unstructured":"Marcus N, Takada H, Law J, Cowan MJ, Gil J, Regueiro JR, et al. Hematopoietic stem cell transplantation for CD3delta deficiency. J Allergy Clin Immunol. 2011;128:1050\u20137.","journal-title":"J Allergy Clin Immunol"},{"key":"626_CR37","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/bmt.2016.232","volume":"52","author":"K Straathof","year":"2017","unstructured":"Straathof K, Anoop P, Allwood Z, Silva J, Nikolajeva O, Chiesa R, et al. Long-term outcome following cyclosporine-related neurotoxicity in paediatric allogeneic haematopoietic stem cell transplantation. Bone Marrow Transpl. 2017;52:159\u201362.","journal-title":"Bone Marrow Transpl"},{"key":"626_CR38","first-page":"23","volume":"15","author":"RC Zuo","year":"2015","unstructured":"Zuo RC, Naik HB, Steinberg SM, Baird K, Mitchell SA, Kuzmina Z, et al. Risk factors and characterization of vitiligo and alopecia areata in patients with chronic graft-vs-host disease. JAMA Dermatol. 2015;15:23\u201332.","journal-title":"JAMA Dermatol"},{"key":"626_CR39","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1600-0560.1983.tb00332.x","volume":"10","author":"AL Claudy","year":"1983","unstructured":"Claudy AL, Schmitt D, Freycon F, Boucheron S. Melanocyte-lymphocyte interaction in human graft-versus-host disease. J Cutan Pathol. 1983;10:305\u201311.","journal-title":"J Cutan Pathol"},{"key":"626_CR40","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1001\/jama.293.6.730","volume":"293","author":"PE Grimes","year":"2005","unstructured":"Grimes PE. New insights and new therapies in vitiligo. J Am Med Assoc. 2005;293:730\u20135.","journal-title":"J Am Med Assoc"},{"key":"626_CR41","doi-asserted-by":"crossref","first-page":"221","DOI":"10.12998\/wjcc.v3.i3.221","volume":"3","author":"GF Mohammed","year":"2015","unstructured":"Mohammed GF, Gomaa AH, Al-Dhubaibi MS. Highlights in pathogenesis of vitiligo. World J Clin Cases. 2015;3:221\u201330.","journal-title":"World J Clin Cases"},{"key":"626_CR42","first-page":"1219","volume":"148","author":"IC Le Poole","year":"1996","unstructured":"Le Poole IC, van den Wijngaard RM, Westerhof W, Das PK. Presence of T cells and macrophages in inflammatory vitiligo skin parallels melanocyte disappearance. Am J Pathol. 1996;148:1219\u201328.","journal-title":"Am J Pathol"},{"key":"626_CR43","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1084\/jem.188.6.1203","volume":"188","author":"GS Ogg","year":"1998","unstructured":"Ogg GS, Rod Dunbar P, Romero P, Chen JL, Cerundolo V. High frequency of skin-homing melanocyte-specific cytotoxic T lymphocytes in autoimmune vitiligo. J Exp Med. 1998;188:1203\u20138.","journal-title":"J Exp Med"},{"key":"626_CR44","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/bmt.2012.187","volume":"48","author":"SE Lee","year":"2013","unstructured":"Lee SE, Cho BS, Kim JH, Yoon JH, Shin SH, Yahng SA, et al. Risk and prognostic factors for acute GVHD based on NIH consensus criteria. Bone Marrow Transpl. 2013;48:587\u201392.","journal-title":"Bone Marrow Transpl"},{"key":"626_CR45","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1182\/blood-2011-06-364265","volume":"119","author":"M Jagasia","year":"2012","unstructured":"Jagasia M, Arora M, Flowers ME, Chao NJ, McCarthy PL, Cutler CS, et al. Risk factors for acute GVHD and survival after hematopoietic cell transplantation. Blood. 2012;119:296\u2013307.","journal-title":"Blood"},{"key":"626_CR46","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/sj.bmt.1701437","volume":"22","author":"Y Sherer","year":"1998","unstructured":"Sherer Y, Shoenfeld Y. Autoimmune diseases and autoimmunity post-bone marrow transplantation. Bone Marrow Transpl. 1998;22:873\u201381.","journal-title":"Bone Marrow Transpl"},{"key":"626_CR47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2017.00052","volume":"8","author":"S Bakhtiar","year":"2017","unstructured":"Bakhtiar S, G\u00e1mez-D\u00edaz L, Jarisch A, Soerensen J, Grimbacher B, Belohradsky B, et al. Treatment of infantile inflammatory bowel disease and autoimmunity by allogeneic stem cell transplantation in LPS-responsive beige-like anchor deficiency. Front Immunol. 2017;8:1\u20139.","journal-title":"Front Immunol"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41409-019-0626-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41409-019-0626-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41409-019-0626-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:15:14Z","timestamp":1684617314000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41409-019-0626-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,29]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["626"],"URL":"https:\/\/doi.org\/10.1038\/s41409-019-0626-x","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,29]]},"assertion":[{"value":"3 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}